Male microchimerism and survival among women

International Journal of Epidemiology

Volumn 43, Issue 1, 2014, Pages 168-173

  Kamper Jørgensen, Mads ^a   Hjalgrim, Henrik ^b   Andersen, Anne Marie Nybo ^a   Gadi, Vijayakrishna K ^c,d   Tjønneland, Anne ^e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Denmark; Epidemiology; Microchimerism; Survival

Indexed keywords

BLOOD; CARDIOVASCULAR DISEASE; CELL ORGANELLE; CHROMOSOME; COHORT ANALYSIS; EPIDEMIOLOGY; SURVIVAL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; MIDDLE AGED; PARITY; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL; VERY ELDERLY; Y CHROMOSOME; BLOOD; CAUSE OF DEATH; CHIMERA; CONFIDENCE INTERVAL; DENMARK; EPIDEMIOLOGY; GENETICS; HEALTH SURVEY; INCIDENCE; MORTALITY; NEOPLASM; POLYMERASE CHAIN REACTION; PREGNANCY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK; RISK FACTOR;

DENMARK;

DNA;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHIMERISM; CHROMOSOMES, HUMAN, Y; CONFIDENCE INTERVALS; DENMARK; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; PREGNANCY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SURVIVAL;

EID: 84896809637     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyt230     Document Type: Article

References (36)

1. Grundy E, Kravdal O. Reproductive history and mortality in late middle age among Norwegian men and women. Am J Epidemiol 2008;167:271-79.
2. Simons LA, Simons J, Friedlander Y, McCallum J. Childbearing history and late-life mortality: the Dubbo study of Australian elderly. Age Ageing 2012;41:523-28.
3. Doblhammer G. Reproductive history and mortality later in life: a comparative study of England and Wales and Austria. Popul Stud (Camb) 2000;54:169-76.
4. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996;93:705-08.
5. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559-62.
6. Willer CJ, Herrera BM, Morrison KM, Sadovnick AD, Ebers GC. Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol 2006; 179:145-51.
7. Rak JM, Maestroni L, Balandraud N et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009;60:73-80.
8. Renne C, Ramos LE, Steimle-Grauer SA et al. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol Metab 2004;89: 5810-14.
9. Kamper-Jørgensen M, Biggar RJ, Tjønneland A et al. Opposite effects of microchimerism on breast and colon cancer. Eur J Cancer 2012;48:2227-35.
10. Cirello V, Perrino M, Colombo C et al. Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues. Int J Cancer 2010;126:2874-78.
11. Gadi VK, Nelson JL. Fetal microchimerism in women with breast cancer. Cancer Res 2007;67:9035-38.
12. Gilmore GL, Haq B, Shadduck RK, Jasthy SL, Lister J. Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Exp Hematol 2008;36: 1073-77.
13. Tjønneland A, Olsen A, Boll K et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 2007;35:432-41.
14. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011;39(Suppl. 7):42-45.
15. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006;53:441-49.
16. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health 2011;39(Suppl. 7):26-29.
17. Lambert NC, Lo YM, Erickson TD et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002;100:2845-51.
18. Kamper-Jørgensen M, Mortensen L, Andersen AM, Hjalgrim H, Gadi VK, Tjønneland A. Predictors of male microchimerism. Chimerism 2012;3:1-8.
19. WHO Collaborating Centers. International Classification of Diseases. Epidemiol Bull 1998;19:7-11.
20. Kleinman K. Testing the Proportionality Assumption. http://sas-and-r.blogspot.dk/2010/06/example-742-testingproportionality.html (20 August 2013, date last accessed).
21. Statistics Denmark. Population and elections. 2007. www.statbank.dk (20 August 2013, date last accessed).
22. Larsen SB, Dalton SO, Schuz J et al. Mortality among participants and non-participants in a prospective cohort study. Eur J Epidemiol 2012;27:837-45.
23. Kara RJ, Bolli P, Karakikes I et al. Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res 2012;110:82-93.
24. Kamper-Jørgensen M. Microchimerism and survival after breast and colon cancer diagnosis. Chimerism 2012;3: 72-73.
25. Kallenbach LR, Johnson KL, Bianchi DW. Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology. Cancer Res 2011;71:8-12.
26. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001;323:1213-17.
27. Holzgreve W, Ghezzi F, Di NE, Ganshirt D, Maymon E, Hahn S. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998;91(5 Pt 1):669-72.
28. Lo YM, Leung TN, Tein MS et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-88.
29. Gammill HS, Guthrie KA, Aydelotte TM, Waldorf KM, Nelson JL. Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host? Blood 2010;116:2706-12.
30. Utter GH, Reed WF, Lee TH, Busch MP. Transfusion-associated microchimerism. Vox Sang 2007;93:188-95.
31. Imanishi D, Miyazaki Y, Yamasaki R et al. Donor-derived DNA in fingernails among recipients of allogeneic hematopoietic stem cell transplantation. Blood 2007;110: 2231-34.
32. de Bellefon LM, Heiman P, Kanaan SB et al. Cells from a vanished twin as a source of microchimerism 40 years later. Chimerism 2011;1:1-5.
33. Westergaard T, Wohlfahrt J, Aaby P, Melbye M. Population based study of rates of multiple pregnancies in Denmark, 1980-94. BMJ 1997;314:775-79.
34. Yan Z, Lambert NC, Guthrie KA et al. Male microchimerism in women without sons: quantitative assessment and correlation with pregnancy history. Am J Med 2005;118: 899-06.
35. Vatten LJ, Forman MR, Nilsen TI, Barrett JC, Romundstad PR. The negative association between preeclampsia and breast cancer risk may depend on the offspring's gender. Br J Cancer 2007;96:1436-38.
36. Wohlfahrt J, Melbye M. Maternal risk of breast cancer and birth characteristics of offspring by time since birth. Epidemiology 1999;10:441-44.